They are meeting British and Swedish regulators to find next...

They are meeting British and Swedish regulators to find next steps to run a trial there. I am somewhat surprised they don't already know what is required, so I guess it is to see if they like the data. It seems like someone is asleep at the wheel, but it just may be that as soon as the FDA data was ready it was presented for discussion and now the EU submission is next in line with that data. It is no use sniping at Dr Shoulson. Prana is lucky to have him on board through this. There are differences of opinion even within the FDA.
Anybody here believe they will keep that fuzzy timeline of "later this month". If they do that I will be more than happy with another EURO trial. No use crying about what was always a possibility with the FDA. We are not the only HD drug developers being obstructed by the FDA.